-+ 0.00%
-+ 0.00%
-+ 0.00%

City Of Hope And Adagene Launch Phase 1 Clinical Trial To Explore Combination Therapy For Patients Battling Metastatic Colorectal Cancer

Benzinga·11/17/2026 13:12:02

Study was designed by medical oncologist to accelerate lifesaving care to patients

City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the United States, and Adagene Inc. ("Adagene") (NASDAQ:ADAG), a platform-driven, clinical-stage biotechnology company transforming the discovery and development of novel antibody-based therapies, today announced the launch of an innovative Phase 1 clinical trial to explore a new combination therapy for patients battling metastatic colorectal cancer, particularly for those whose disease has resisted standard treatments.